about
Cardiac conduction defects associate with mutations in SCN5AKLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephronAbsence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in humanDefects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillationMultifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathyMitral valve disease--morphology and mechanisms.Biallelic PPA2 Mutations Cause Sudden Unexpected Cardiac Arrest in InfancyDesmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practiceCommon variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac deathMolecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channelGenetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarizationValvular dystrophy associated filamin A mutations reveal a new role of its first repeats in small-GTPase regulation.New Family With Catecholaminergic Polymorphic Ventricular Tachycardia Linked to the Triadin Gene.Monomorphic ventricular tachycardia due to Brugada syndrome successfully treated by hydroquinidine therapy in a 3-year-old child.Sodium channel blocker tests allow a clear distinction of electrophysiological characteristics and prognosis in patients with a type 2 or 3 Brugada electrocardiogram pattern.SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome.Long-term follow-up of patients with short QT syndrome.Ventricular fibrillation in loop recorder memories in a patient with early repolarization syndrome.Prevalence, characteristics, and prognosis role of type 1 ST elevation in the peripheral ECG leads in patients with Brugada syndrome.Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.Prevalence and prognostic role of various conduction disturbances in patients with the Brugada syndrome.Increased Tpeak-Tend interval is highly and independently related to arrhythmic events in Brugada syndrome.Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis.Impact of clinical and genetic findings on the management of young patients with Brugada syndrome.Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1.An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.PQ segment depression in patients with short QT syndrome: a novel marker for diagnosing short QT syndrome?Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study.Genetic association analyses highlight biological pathways underlying mitral valve prolapse.Fine-scale human genetic structure in Western France.Dysfunction of the Voltage-Gated K+ Channel β2 Subunit in a Familial Case of Brugada Syndrome.Variants in the SCN5A Promoter Associated With Various Arrhythmia PhenotypesRisk of ventricular arrhythmia in patients with myocardial infarction and non-obstructive coronary arteries and normal ejection fraction.Cardiac remote monitoring in France.Inherited progressive cardiac conduction disorders.Value of the sodium-channel blocker challenge in Brugada syndrome.Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity.The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.Safety, feasibility, and outcome results of cardiac resynchronization with triple-site ventricular stimulation compared to conventional cardiac resynchronization.Prognostic significance of fever-induced Brugada syndrome.
P50
Q22010507-02877E0C-2DD8-4F4E-AE3F-C06BB0B250BFQ24307394-39A52A77-62B5-4346-ABF7-F098A62773AEQ24307681-EA917800-2F2D-423E-AC48-D9397355A2F8Q24324744-938E5B34-8194-4878-9DDA-01FF163FAE47Q24339527-87F70795-F14B-4651-9C1C-B8CF75F6EDF3Q26781699-D5C42CAD-1E61-4815-AAD1-ADEEC4C6D595Q28118657-3BF9B381-9F0A-40F7-89B1-6BA8A01E8A1AQ28279991-FE4E4F54-7FC4-44A8-A803-01E8C7777029Q28294931-E5B9D731-C8FF-4ADB-B058-490E26DF6BEAQ28485378-79770EDF-B05A-4A04-B246-416A3835FBA1Q28654771-BF67E388-1AA3-4F07-8C34-174F3BC39CD2Q30572197-56217677-16F0-4763-9017-A98F9A1A2FB4Q30982059-1B4BA483-81E2-468E-BA6D-2729E8334A1EQ33153506-389C421B-3E90-4BB8-8636-7F77CBA21FFDQ33156794-15DCF0DB-DF9F-4A56-B786-A0271E1B079AQ33158197-E395C26A-DADF-4725-A676-59661D8BC508Q33160301-BAE03D7F-6997-4F25-A270-A29DF77AEA9AQ33160358-D287C0F6-89CA-4C7A-BF3D-B4B55B51FEE7Q33162521-99CB1ED9-4A02-4F71-9DEF-06A16FC25F99Q33163052-8ECFEFDA-D115-46E3-88FB-3177C82BFBB3Q33163244-FA4A576C-6B95-4D19-8C9F-931224E083D9Q33166047-97F18449-2525-4558-B615-22045478B3D2Q33166717-4FD4DD79-A23F-41D5-9D07-3B14C5E998E7Q33166854-94C49F7E-F4CE-4318-9C52-BD3B91B5371BQ33167996-2B0D589E-A84D-472E-B6C4-39C24653D75EQ33655317-3EFED8F4-CD41-45F2-B8FC-24B27F45CC73Q33942230-7B298826-0B6C-44E7-8CA0-C9FFC3FD3BE8Q35661823-089E57D9-8664-4717-B95A-5E38BE4D27BCQ36638702-30925111-0AFD-4930-9389-B664160CFC13Q36695178-CBE32B47-3489-4BC2-A675-E2103742284CQ37076110-C741C55D-C39D-45E4-B266-25291F506D01Q37364440-E2B22123-44B9-4CE4-9E6B-E82A78E07121Q37724064-7AA31FC0-51EA-45B5-B4FB-40CF2C873CE4Q38202744-55956531-63E3-4058-8A93-674643D7E545Q38271658-528A7EE6-8C84-43D1-9995-5E4659266ED4Q38636386-E4743B25-E104-420A-87B8-6F4E3C374F91Q38699395-27258788-A055-48C5-8936-4F9668A64930Q38836220-59AF4378-C0C8-42E3-85BF-62889B657975Q38968726-EC5240DD-BE88-45E8-B645-DDA48AE3F852Q40111696-F53CD078-4F54-4352-830E-4F1CD9876019
P50
description
researcher ORCID ID = 0000-0002-5492-8619
@en
wetenschapper
@nl
name
Vincent Probst
@ast
Vincent Probst
@en
Vincent Probst
@es
Vincent Probst
@nl
type
label
Vincent Probst
@ast
Vincent Probst
@en
Vincent Probst
@es
Vincent Probst
@nl
prefLabel
Vincent Probst
@ast
Vincent Probst
@en
Vincent Probst
@es
Vincent Probst
@nl
P1053
D-4996-2015
P106
P21
P31
P496
0000-0002-5492-8619